文献速递脊柱关节炎

银屑病关节炎试验中躯体功能测量工具辨别力的比较:一项元流行病学研究

Determining the best discriminatory physical functioning outcome measurement instrument for psoriatic arthritis trials: A meta-epidemiological study.
PubMed 文献 · Semin Arthritis Rheum · 2025-12-29

该研究基于42篇文章(31项随机对照试验)的网络元分析,比较HAQ-DI、SF36-PF和SF36-PCS在银屑病关节炎(PsA)试验中对躯体功能的辨别能力。结果显示HAQ-DI与SF36-PF对变化的反应性相当,且均优于SF36-PCS。

要点

  • HAQ-DI与SF36-PF对变化的反应性相当,无显著差异。
  • HAQ-DI和SF36-PF的反应性均优于SF36-PCS。
  • HAQ-DI与SF36-PCS的SMD差异为0.057(95%CI 0.003-0.110)。

核心结论

  • 在PsA随机对照试验中,HAQ-DI和SF36-PF对变化的反应性相当,且均优于SF36-PCS。
  • 研究展示了一种定量比较特定领域不同结局测量工具性能的新方法。

研究设计与样本

  • 采用网络元分析技术,样本为银屑病关节炎的随机对照试验。
  • 从42篇文章(31项RCT)中提取数据,计算各测量工具的净效应量估计值(标准化均数差,SMD)。
  • 应用多重治疗元分析在试验水平比较各测量工具的SMD差异。

主要发现

  • HAQ-DI与SF36-PCS直接比较的SMD差异为0.057(95%CI 0.003至0.110)。
  • SF36-PF与SF36-PCS直接比较的SMD差异为0.101(95%CI 0.018至0.184)。
  • HAQ-DI与SF36-PF直接比较的SMD差异为0.059(95%CI 0.142至0.024)。
  • 网络元分析确认HAQ-DI和SF36-PF均比SF36-PCS对变化更敏感,SMD差异分别为0.057(95%CI 0.003至0.110)和0.109(95%CI 0.032至0.185)。
  • HAQ-DI与SF36-PF之间未观察到辨别能力差异。

关键数值与推荐

  • HAQ-DI与SF36-PF反应性相当,无显著差异。
  • HAQ-DI和SF36-PF的反应性均优于SF36-PCS。

临床怎么用

  • 在PsA随机对照试验中,优先选择HAQ-DI或SF36-PF评估躯体功能,因其对变化的反应性优于SF36-PCS。
  • HAQ-DI与SF36-PF可互换使用,两者辨别能力无差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To empirically compare the discriminant capacities of three outcome measurement instruments for assessment of physical functioning for psoriatic arthritis (PsA): HAQ-DI, SF36-PF and SF36-PCS. METHODS: We applied a network meta-analysis technique in a sample of randomized trials (RCTs) for PsA. For randomized comparison, we calculated net effect size estimates for each outcome measurement instrument using standardized mean differences (SMDs); positive values indicated a beneficial effect of the intervention compared to the control groups. We analyzed the differences between outcome measurement instruments at the trial level by applying a multiple-treatment meta-analysis to compare the SMDs within and across randomized comparisons for each outcome measurement instrument. RESULTS: From 42 articles (31 RCTs), 57, 18, and 18 randomized comparisons enabled a direct comparison between HAQ-DI and SF36-PCS (difference in SMDs: 0.057, 95 % confidence interval, CI: 0.003 to 0.110), SF36-PF and SF36-PCS (difference in SMDs: 0.101, 95 % CI: 0.018 to 0.184); and HAQ-DI and SF36-PF (difference in SMDs:0.059, 95 % CI:0.142 to 0.024), respectively. The network meta-analysis technique confirmed that both HAQ-DI and SF36-PF were more responsive to change than SF36-PCS, with differences between SMDs of 0.057 (95 % CI: 0.003 to 0.110) and 0.109 (95 % CI: 0.032 to 0.185), respectively. No difference in discriminatory capacity between HAQ-DI and SF36-PF was noted. CONCLUSIONS: HAQ-DI and SF-36-PF were equally responsive to change and superior to SF36-PCS in PsA RCTs. We illustrated a new method for quantitative comparison of the performance of different outcome measurement instruments for a particular domain.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Leung YY, Haugegaard T, Annfeldt TK, et al. Determining the best discriminatory physical functioning outcome measurement instrument for psoriatic arthritis trials: A meta-epidemiological study. Semin Arthritis Rheum. 2025. PMID: 41494365. doi:10.1016/j.semarthrit.2025.152907

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。